Yun Yen's most recent trade in Lixte Biotechnology Holdings Inc was a trade of 11,632 Options to Purchase Common Stock done . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lixte biotech Holdings Inc | Yun Yen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 11,632 | 11,632 | - | - | Options to Purchase Common Stock | |
| Lixte biotech Holdings Inc | Yun Yen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 10,000 | 10,000 | - | - | Options to Purchase Common Stock | |
| Lixte biotech Holdings Inc | Yun Yen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 8,777 | 8,777 | - | - | Options to Purchase Common Stock | |
| Lixte biotech Holdings Inc | Yun Yen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2025 | 4,545 | 4,545 | - | - | Options to Purchase Common Stock | |
| Lixte biotech Holdings Inc | Yun Yen | Director | 30 Sep 2024 | 5,786 | 5,786 | - | - | Options to Purchase Common Stock | ||
| Lixte biotech Holdings Inc | Yun Yen | Director | 30 Jun 2024 | 10,000 | 10,000 | - | - | Options to Purchase Common Stock | ||
| Lixte biotech Holdings Inc | Yun Yen | Director | 30 Jun 2024 | 4,527 | 4,527 | - | - | Options to Purchase Common Stock | ||
| Lixte biotech Holdings Inc | Yun Yen | Director | 30 Jun 2023 | 10,000 | 10,000 | - | - | Options to Purchase Common Stock | ||
| Lixte biotech Holdings Inc | Yun Yen | Director | 30 Jun 2022 | 100,000 | 100,000 | - | - | Options to Purchase Common Stock | ||
| Fulgent Genetics Inc | Yun Yen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 2,000 | 2,000 (0%) | 0% | 0 | Common Stock | |
| Lixte biotech Holdings Inc | Yun Yen | Director | 30 Jun 2021 | 100,000 | 100,000 | - | - | Options to Purchase Common Stock | ||
| Fulgent Genetics Inc | Yun Yen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) |